(Bloomberg) -- Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000 in the US, according to a study that revives questions about ...
Ludovic Marin—POOL/AFP/Getty Images Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000 in the US, according to a study that ...
Last year was called the year of Ozempic, though it was also a year of Ozempic backlash and Ozempic shortages, which could persist for years. Even so, we appear very far from a peak for GLP-1 ...
RoboMarkets has successfully renewed its platinum partnership with Team AutoLife, a Cyprus-based racing team famous for competing in international rallies and cross-country races. ...
The Danish firm - controlled by the world's biggest charitable foundation - became Europe's biggest company by stock market ...
European countries are reversing decades of peacetime policy to reignite their war engines. Others never stopped and are only ...
Sen. Bernie Sanders, I-Vt., is accusing Novo Nordisk, the maker of popular weight-loss drugs like Ozempic, of gouging prices for customers in the United States. During a Tuesday appearance on ...
Barb was nearly 60 years old, and weighed about 400 pounds. She has type 2 diabetes, chronic kidney disease, and a host of ...
Opinions expressed by Forbes Contributors are their own. I write about men in tights and the money they make for men in suits. The wait is over, and WWE has announced a TV deal with Netflix NFLX ...
Data security company Rubrik Inc. has set terms for its initial public offering, which puts it on course to be valued are more than $5 billion. The California-based company said in a filing ...